Co-Founder
C
ConcR
Concr provides predictive modeling solutions using advanced computational methods derived from astrophysics to accurately forecast individual and cohort responses to cancer therapies. This technology enhances the design of clinical trials and improves the probability of success for novel cancer treatments, particularly in early-stage trials and rare cancers.
- Artificial Intelligence
- Data & Analytics
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$3.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Concr provides predictive modeling solutions using advanced computational methods derived from astrophysics to accurately forecast individual and cohort responses to cancer therapies. This technology enhances the design of clinical trials and improves the probability of success for novel cancer treatments, particularly in early-stage trials and rare cancers.